174 related articles for article (PubMed ID: 27234321)
1. Metastatic melanoma: Pathologic characterization, current treatment, and complications of therapy.
Wick MR; Gru AA
Semin Diagn Pathol; 2016 Jul; 33(4):204-18. PubMed ID: 27234321
[TBL] [Abstract][Full Text] [Related]
2. Investigating the metastatic niche in melanoma: a new therapeutic opportunity?
Aladowicz E; Lanfrancone L
Future Oncol; 2014 Apr; 10(5):699-701. PubMed ID: 24799050
[No Abstract] [Full Text] [Related]
3. Illuminating progression: tracking melanoma metastasis in a gene therapy setting.
Day CP; Merlino G
Pigment Cell Melanoma Res; 2011 Apr; 24(2):260-1. PubMed ID: 21226857
[No Abstract] [Full Text] [Related]
4. Management of primary cutaneous and metastatic melanoma.
Rubin KM
Semin Oncol Nurs; 2013 Aug; 29(3):195-205. PubMed ID: 23958217
[TBL] [Abstract][Full Text] [Related]
5. [Regression of melanoma metastases after immunological therapy].
Malek-Mansour S; Castermans-Elias S; Lapière CM
Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
[No Abstract] [Full Text] [Related]
6. Melanoma--part 2: management.
Thirlwell C; Nathan P
BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
[No Abstract] [Full Text] [Related]
7. [Vaccination therapy of melanoma].
Schuler-Thurner B; Schuler G
J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
[No Abstract] [Full Text] [Related]
8. Therapy for metastatic melanoma: an overview and update.
Boyle GM
Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
[TBL] [Abstract][Full Text] [Related]
9. Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
Richtig G; Ramelyte E; Koch L; Greinix H; Ferrone S; Dummer R; Richtig E
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e381-e383. PubMed ID: 31081948
[No Abstract] [Full Text] [Related]
10. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
Ireland A; Millward M; Pearce R; Lee M; Ziman M
Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
[TBL] [Abstract][Full Text] [Related]
11. [New treatments for metastatic melanoma: a first hope].
Robert C; Mateus C
Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
[No Abstract] [Full Text] [Related]
12. Re: Cook et al. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002; 197: 188-193.
Heenan PJ; Taran JM
J Pathol; 2003 Jan; 199(1):132; author reply 132-3. PubMed ID: 12474238
[No Abstract] [Full Text] [Related]
13. Melanoma: from darkness to promise.
Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
[TBL] [Abstract][Full Text] [Related]
14. Melanoma.
Benson C; Gore ME
Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
[No Abstract] [Full Text] [Related]
15. [Ultra-late metastasis of melanoma with secondary dissemination along the venous stripping line].
Nicolas C; Reichert-Penetrat S; Granel F; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2000 Jan; 127(1):60-3. PubMed ID: 10717565
[TBL] [Abstract][Full Text] [Related]
16. New trends in the treatment of malignant melanoma.
Veronesi U; Bajetta E; Cascinelli N; Clemente C; Rilke F
Int Adv Surg Oncol; 1978; 1():113-56. PubMed ID: 399762
[No Abstract] [Full Text] [Related]
17. Resistance patterns to anti-PD-1 therapy in metastatic melanoma.
Ozgun A; Sondak VK; Markowitz J
Chin Clin Oncol; 2016 Dec; 5(6):75. PubMed ID: 27701871
[No Abstract] [Full Text] [Related]
18. ["Pathomorphosis" of skin melanomas in the comprehensive treatment using hyperthermia].
Aleksandrov NN; Neborak IuT; Furmanchuk AV; Zhavrid EA; Fradkin SZ
Vopr Onkol; 1979; 25(1):19-26. PubMed ID: 425393
[TBL] [Abstract][Full Text] [Related]
19. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
Damian DL; Saw RP; Thompson JF
J Surg Oncol; 2014 Mar; 109(4):308-13. PubMed ID: 24522938
[TBL] [Abstract][Full Text] [Related]
20. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
Koon HB; Atkins MB
Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
